Monika Trawinska Malgorzata

One Size Does Not Fit to All: Intolerant or Resistant CML Patients Could Benefit from Different Ponatinib Starting Dose Strategies. Multicenter Italian Experience

M. Baccarani, G. Rosti, G. Saglio, 2018, Blood.